The Oncology Institute, Inc.
NASDAQ:TOI
0.3165 (USD) • At close December 27, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2018 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 99.901 | 98.578 | 94.666 | 85.788 | 82.035 | 80.224 | 76.192 | 71.424 | 64.977 | 60.921 | 55.161 | 52.304 | 52.275 | 49.843 | 48.58 | 187.515 | 47.249 | 47.28 | 44.02 | 37.359 |
| Kosten van de omzet
| 85.535 | 85.552 | 84.186 | 72.986 | 66.057 | 65.107 | 62.093 | 55.795 | 51.977 | 49.779 | 42.839 | 43.971 | 40.852 | 38.954 | 38.378 | 66.723 | 37.676 | 37.791 | 37.046 | 28.931 |
| Brutowinst
| 14.366 | 13.026 | 10.48 | 12.802 | 15.978 | 15.117 | 14.099 | 15.629 | 13 | 11.142 | 12.322 | 8.333 | 11.423 | 10.889 | 10.202 | 120.792 | 9.573 | 9.488 | 6.974 | 8.428 |
| Brutowinstmarge
| 0.144 | 0.132 | 0.111 | 0.149 | 0.195 | 0.188 | 0.185 | 0.219 | 0.2 | 0.183 | 0.223 | 0.159 | 0.219 | 0.218 | 0.21 | 0.644 | 0.203 | 0.201 | 0.158 | 0.226 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.525 | 1.525 | 2.533 | 0.135 | 0.148 | 0.148 | 0.145 | 0.038 | 0 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46.72 | 11.205 | 8.679 | 11.043 | 41.418 | 0 | 8.403 | 8.784 | 0 |
| Verkoop-, algemene en administratieve kosten
| 26.646 | 27.872 | 28.452 | 28.088 | 28.205 | 28.726 | 28.83 | 29.572 | 31.963 | 28.348 | 29.806 | 48.245 | 12.73 | 11.212 | 11.178 | 41.566 | 0.148 | 8.547 | 8.822 | 8.833 |
| Overige kosten
| 1.573 | 1.518 | 0.068 | -0.35 | -0.14 | -0.357 | 1.269 | 1.192 | 1.134 | 1.098 | 0.987 | -0.08 | 0.054 | -0.004 | 1.076 | 3.028 | 0.05 | 1.018 | 0 | 0.764 |
| Bedrijfskosten
| 28.219 | 29.39 | 28.452 | 28.088 | 29.903 | 30.055 | 30.099 | 30.764 | 33.097 | 29.446 | 30.793 | 49.164 | 13.58 | 12.006 | 11.955 | 44.594 | 0.198 | 9.348 | 17.083 | 9.598 |
| Bedrijfsresultaat
| -13.853 | -16.364 | -17.972 | -15.286 | -13.925 | -14.938 | -16 | -15.135 | -20.097 | -18.304 | -18.471 | -40.831 | -2.157 | -1.117 | -1.753 | -7.715 | -0.198 | 0.14 | -2.643 | -1.17 |
| Bedrijfsresultaat ratio
| -0.139 | -0.166 | -0.19 | -0.178 | -0.17 | -0.186 | -0.21 | -0.212 | -0.309 | -0.3 | -0.335 | -0.781 | -0.041 | -0.022 | -0.036 | -0.041 | -0.004 | 0.003 | -0.06 | -0.031 |
| Totaal overige inkomsten en kosten netto
| -2.26 | 0.885 | -1.917 | -3.78 | -3.359 | -1.86 | 2.913 | 13.705 | 17.399 | 12.819 | 37.937 | 28.208 | -0.024 | 5.101 | 0.975 | -3.06 | -2.206 | 0.908 | -7.507 | -0.002 |
| Inkomen voor belasting
| -16.113 | -15.479 | -19.889 | -18.841 | -17.284 | -16.798 | -29.954 | -9.379 | -2.698 | -5.485 | 19.466 | -12.623 | -2.181 | 3.984 | -0.778 | -9.014 | -2.404 | 1.047 | -10.15 | -1.171 |
| Inkomen voor belasting ratio
| -0.161 | -0.157 | -0.21 | -0.22 | -0.211 | -0.209 | -0.393 | -0.131 | -0.042 | -0.09 | 0.353 | -0.241 | -0.042 | 0.08 | -0.016 | -0.048 | -0.051 | 0.022 | -0.231 | -0.031 |
| Belastingkosten
| 0 | 0 | -3.617 | -0.087 | 0.135 | 0.099 | 0.044 | 0.123 | -0.024 | -0.032 | 0.18 | -2.467 | 0.799 | 0.78 | 0.218 | -0.505 | 0.013 | 0.029 | 0.304 | 0.822 |
| Nettowinst
| -16.113 | -15.479 | -16.272 | -15.314 | -17.419 | -16.897 | -29.998 | -9.502 | -2.674 | -5.453 | 15.767 | -10.156 | -2.98 | 3.205 | -0.996 | -8.509 | -2.417 | 1.018 | -9.846 | -1.994 |
| Nettowinstmarge
| -0.161 | -0.157 | -0.172 | -0.179 | -0.212 | -0.211 | -0.394 | -0.133 | -0.041 | -0.09 | 0.286 | -0.194 | -0.057 | 0.064 | -0.021 | -0.045 | -0.051 | 0.022 | -0.224 | -0.053 |
| WPA (Winst Per Aandeel)
| -0.18 | -0.17 | -0.22 | -0.21 | -0.24 | -0.23 | -0.41 | -0.13 | -0.034 | -0.075 | 0.22 | -0.15 | -0.04 | 0.05 | -0.015 | -0.3 | -0.084 | 0.015 | -0.43 | -0.03 |
| Verwaterde WPA
| -0.18 | -0.17 | -0.22 | -0.21 | -0.24 | -0.23 | -0.41 | -0.11 | -0.034 | -0.075 | 0.21 | -0.15 | -0.04 | 0.05 | -0.015 | -0.3 | -0.084 | 0.015 | -1.71 | -0.03 |
| EBITDA
| -12.315 | -14.846 | -16.415 | -20.009 | -12.891 | -13.554 | -26.035 | -5.737 | -0.067 | -4.326 | -15.964 | -11.644 | -1.576 | -0.326 | -0.237 | -8.043 | -0.198 | 0.941 | -1.848 | -0.405 |
| EBITDA ratio
| -0.123 | -0.151 | -0.174 | -0.16 | -0.139 | -0.161 | -0.176 | -0.186 | -0.292 | -0.282 | -0.32 | -0.765 | -0.024 | -0.007 | 0.002 | -0.075 | 0.044 | 0.041 | -0.042 | -0.011 |